Key points are not available for this paper at this time.
This editorial refers to ‘Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population’, by A.M.D. Kristense
Raveendra et al. (Fri,) studied this question.